Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - evommune
Get the latest updates from Google Alert - evommune directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 2 hours ago
Hereditary Angioedema: Clinical Decision-Making and Emerging Therapies - Medscape
about 3 hours ago
... Evommune; Jasper; TEVA; Yuhan; Pfizer; Enanta; RAPT Serve(d) as a speaker...
Biggest gainers and losers for Dec. 8-12, 2025 | BioWorld
about 5 hours ago
Evommune, -17.76%, Belite Bio, -$8.68. Rigel Pharma, -16.64%, Lenz Thera, -$8.58. Xoma...
Evommune CEO 'There's Still a Lot to Do' to Defeat Chronic Inflammation - YouTube
about 7 hours ago
This content isn't available. Evommune CEO 'There's Still a Lot to Do'...
斯蒂芬斯調整2026 年羅素重組的觀點- Reuters - TradingView
about 8 hours ago
CDNL、Evommune EEVMN和Hyperliquid Strategies PPURR準備加入羅素2000指數。 (查克-米科拉查克). *****. 早些時候的實時市場：. DATTREK 2026 年提示表：哪些 ...
Buy Rating for Evommune, Inc. Driven by EVO756's Promising Phase II Trial Potential
about 14 hours ago
William Blair analyst Matt Phipps has reiterated their bullish stance on EVMN...
Invea Therapeutics, Oral Small‑Molecule IMID Therapies, Files for Nasdaq Capital Market IPO
about 16 hours ago
Key competitors: Omalizumab (Xolair), Dupixent (Dupixent), Remibrutinib (Rhapsido), and developers such as...
Evommune (EVMN) Q3: Revenue Jump Reinforces Bullish Growth Narrative Despite ...
2 days ago
Q3 2025 Snapshot and Recent Trends Evommune (EVMN) just posted Q3 2025...
EVOMMUNE, INC. (EVMN) Stock, Price, News, Quotes, Forecast and Insights | MSN Money
3 days ago
THERIVA BIOLOGICS, INC. 0.22. -6.58%. NUVATION BIO INC. 8.43. + ...
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Evommune, Inc ...
3 days ago
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Evommune, Inc. (EVMN)...
Evommune (NYSE:EVMN) Stock Valuation, Peer Comparison & Price Targets
3 days ago
Research Evommune's (NYSE:EVMN) stock key valuation metrics while comparing it with its...
CEO Pena Surrenders 28138 Of Evommune Inc [EVMN] - TradingView
3 days ago
Pena Luis C Chief Executive Officer of Evommune Inc [EVMN] filed a...
These Bay Area companies are IPO contenders in 2026 - San Francisco Business Times
3 days ago
Biotechs that have gone public this year include Redwood City-based MapLight Therapeutics...